Physician

Mehnaz Khan, M.D.

According to 2025 Medicare claims, Mehnaz Khan, M.D. (NPI: 1740575067) practices ophthalmology in the Boston, MA market, with the plurality of this provider's patient population coming from Norfolk, MA. This provider's primary affiliated billing organization is ATRIUS HEALTH, INC. (NPI: 1871639914; TIN: 043397450) and primary practice location at 02184-4998. Khan is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641) and Atrius Health, Inc. (ACO ID: A5088), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 878 traditional Medicare patients, billed 8,811 HCPCS/CPT codes, and received $781,954 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 182 prescription claims across 62 beneficiaries totaling $7,472 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,884 to $781,954. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,701 and ending at $7,472. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	45	55	$4,884
2016	216	318	$19,446
2017	476	3,246	$563,628
2018	549	5,031	$768,845
2019	507	4,431	$724,189
2020	504	2,431	$379,889
2021	666	3,335	$489,733
2022	819	4,450	$662,729
2023	875	5,208	$907,179
2024	878	8,811	$781,954

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	45	123	$10,701
2016	27	49	$1,741
2017	57	140	$6,232
2018	73	194	$7,066
2019	56	148	$5,535
2020	47	156	$8,388
2021	57	192	$10,004
2022	58	174	$7,071
2023	67	229	$7,992
2024	62	182	$7,472

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	109	469	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	701	1,192	$97
92014	Established patient complete exam of visual system	156	208	$93
92134	Imaging of retina	749	1,537	$32
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	107	126	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	53	1,273	$1,628
Ketorolac Tromethamine	Ketorolac Tromethamine	38	890	$428
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	22	1,295	$247
Latanoprost	Latanoprost	19	1,300	$205

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mehnaz Khan, M.D.?

Tedicare shows public-source Medicare data for Mehnaz Khan, M.D. (NPI 1740575067), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mehnaz Khan, M.D. have ACO affiliation data?

Mehnaz Khan, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641) and Atrius Health, Inc. (MSSP, ACO ID A5088).

What billing organization is linked to Mehnaz Khan, M.D.?

Mehnaz Khan, M.D. is linked to ATRIUS HEALTH, INC. (billing NPI 1871639914) in the available physician profile data.

Does Mehnaz Khan, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.